ArticleTherapeutic advances in medical oncology2023

Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens.

Thomas Chaigneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.